Status:
COMPLETED
Effect of Ultra-low Dose Naloxone During Supraclavicular Brachial Plexus Block on Post-operative Opioi
Lead Sponsor:
Mansoura University
Conditions:
Upper Extremity Trauma
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Effective post-operative pain control can reduce patient morbidity and affect the patient outcome. Brachial plexus block is one of them, a popular and widely employed regional nerve block technique fo...
Detailed Description
The aim of this study is to evaluate the effect of ultra-low dose of naloxone when added to bupivacaine %.05 in supraclavicular brachial plexus block in orthopedic upper limb surgery and if it enhance...
Eligibility Criteria
Inclusion
- American Society of Anesthesiology (ASA) physical state class Ι and II
- Elective upper limb orthopedic surgery (hand, forearm and elbow)
- Duration of surgery ≤180 min
- BMI ≤30 kg/m2
Exclusion
- History of allergy to the drug of the study.
- Coagulation disorders
- Infection at the puncture site.
- Pregnancy
- Opioid abuse.
- Abuse of tranquilizers
Key Trial Info
Start Date :
December 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2018
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03372486
Start Date
December 18 2017
End Date
April 25 2018
Last Update
May 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University, Central Hospital, emergency Unit
Al Mansurah, Dakahlia Governorate, Egypt, 050